Chemical pneumonitis: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Chemical pneumonitis}} | {{Chemical pneumonitis}} | ||
| Line 18: | Line 5: | ||
'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | '''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | ||
==[[Chemical pneumonitis overview|Overview]]== | ==[[Chemical pneumonitis overview|Overview]]== | ||
| Line 30: | Line 18: | ||
==[[Chemical pneumonitis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Chemical pneumonitis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Chemical pneumonitis risk factors|Risk | ==[[Chemical pneumonitis risk factors|Risk Factors]]== | ||
==[[Chemical pneumonitis natural history, complications, and prognosis|Natural History, Complications and Prognosis]]== | ==[[Chemical pneumonitis natural history, complications, and prognosis|Natural History, Complications and Prognosis]]== | ||
| Line 40: | Line 28: | ||
==Treatment== | ==Treatment== | ||
[[Chemical pneumonitis medical therapy|Medical Therapy]] | [[Status asthmaticus primary prevention|Primary Prevention]] | [[Status asthmaticus secondary prevention|Secondary Prevention]] | [[Status asthmaticus cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Status asthmaticus future or investigational therapies|Future or Investigational Therapies]] | [[Chemical pneumonitis medical therapy|Medical Therapy]] | [[Status asthmaticus primary prevention|Primary Prevention]] | [[Status asthmaticus secondary prevention|Secondary Prevention]] | [[Status asthmaticus cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Status asthmaticus future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | |||
[[Category:Toxicology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Disease]] | |||
[[Category:Infectious disease]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 20:26, 6 December 2012
|
Chemical pneumonitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chemical pneumonitis On the Web |
|
American Roentgen Ray Society Images of Chemical pneumonitis |
For patient information click here
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Chemical pneumonitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria | History and Symptoms | Physical Examination | Other studies | Chest X Ray
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies